36 Participants Needed

Nerve Fiber Stimulation for Alcoholism

PD
cc
Overseen Bycharles chabal, MD
Age: 18+
Sex: Any
Trial Phase: Phase 1
Sponsor: Soovu Labs Inc.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

CT fibers are found in the skin of most mammals and project to the insular cortex. Stimulation of CT fibers by light touch causes a release of oxytocin and is associated with feelings of comfort and wellbeing. Peripheral TRPV-1 channels are important in pain transmission and modulation of the stress response likely through the central release of oxytocin and are stimulated by heat. In Phase 1 investigators will test stimulation of TRPV1 channels and CT fibers in human subjects to correlate the lab findings with subjective human responses and test whether stimulation of CT fibers and TRPV-1 channels reduce anxiety and stress in subjects who suffer from AUD. Aim 1 and 2. We will define the optimal parameters for CT fiber stimulation for force, temperature, and body location. We will perform similar testing for peripheral thermal stimulation (TRPV-1) using our commercially available heating pods. Parameters tested will include the optimal body location, number of heating pods (2-4) and temperature of pods. In Aim 3 investigators will simultaneously apply both CT fiber and thermal stimulation in a proof of concept study. The experimental group will receive active CT fiber and thermal stimulation and the control group non-physiologic placebo stimulation. Subjects with a history of AUD will be randomized into control versus experimental groups and undergo stress using a validated mental calculation stressors. Stress, cravings, and anxiety will be measured using standardized assessments, and investigators will measure salivary oxytocin and cortisol levels, potentially biomarkers.

Research Team

cc

charles chabal, MD

Principal Investigator

soovu labs

Eligibility Criteria

This trial is for individuals who have had Alcohol Use Disorder (AUD) within the last six months. It's not suitable for those with unstable medical or psychological conditions.

Inclusion Criteria

A history of AUD within the past six months

Exclusion Criteria

Unstable medical or psychological status

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive experimental stimulation of TRPV-1 channels and CT fibers, followed by a stressor and further stimulation

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments at 30 and 60 minutes post-treatment

90 minutes

Treatment Details

Interventions

  • C Tactile Fiber Stimulation
  • Heat Stimulation
Trial Overview The study tests if stimulating skin fibers and heat channels can reduce stress and anxiety in AUD sufferers. Participants will be split into groups, some getting real stimulation and others placebo, to see which works better.
Participant Groups
3Treatment groups
Active Control
Group I: Placebo heat and active c tactile stimulationActive Control2 Interventions
Subjects will receive an active c tactile stimulation device and a sham heating device.
Group II: Active heat and placebo c tactile stimulationActive Control2 Interventions
Subjects will receive an active heating device and a sham c tactile stimulation device.
Group III: Active heat and active c tactile stimulationActive Control2 Interventions
Subjects will receive an active c tactile stimulation device and an active heating device.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Soovu Labs Inc.

Lead Sponsor

Trials
5
Recruited
240+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security